Chaoju Eye Care Holdings Limited (HKG:2219)

Market Cap	1.78B -15.7%
Revenue (ttm)	1.50B -3.0%
Net Income	188.77M -19.8%
EPS	0.26 -22.9%
Shares Out	693.38M
PE Ratio	9.75
Forward PE	8.09
Dividend	0.12 (4.64%)
Ex-Dividend Date	Jun 10, 2025

Volume	491,500
Average Volume	353,287
Open	2.570
Previous Close	2.570
Day's Range	2.480 - 2.650
52-Week Range	2.400 - 3.310
Beta	0.51
RSI	33.47
Earnings Date	Mar 26, 2026

About Chaoju Eye Care Holdings

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye di...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1988
• Employees: 2,627
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2219

Financial Performance

In 2024, Chaoju Eye Care Holdings's revenue was 1.41 billion, an increase of 2.62% compared to the previous year's 1.37 billion. Earnings were 195.08 million, a decrease of -14.78%.

Financial numbers in CNY